Complex containing oligonucleotide having immunopotentiating activity and use thereof
US10202606B2 · kind B2 · utility
3Cited by
3References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 19, 2014 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Sep 19, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an oligodeoxynucleotide containing humanized K type CpG oligodeoxynucleotide and poly deoxyadenylate, wherein the poly deoxyadenylate is placed on the 3′-side of the humanized K type CpG oligodeoxynucleotide. In addition, the present invention provides a complex containing the aforementioned oligodeoxynucleotide and β-1,3-glucan.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.